US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

PHVS Pharvaris NV

18.83

-0.67 (-3.44%)

Última actualización: 13:10:33

Retrasado por 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/19/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Johannes Gerardus Christiaan Petrus Schikan

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Pharvaris NV (NASDAQ:PHVS)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024

Haga Click aquí para más Gráficas Pharvaris NV.

Pharvaris NV (NASDAQ:PHVS)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024

Haga Click aquí para más Gráficas Pharvaris NV.

Noticias sobre Pharvaris NV PHVS

Form 144 - Report of proposed sale of securities
Lunes 2 de Diciembre 2024 (4 semanas hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Miércoles 13 de Noviembre 2024 (1 mes hace) • Edgar (US Regulatory)

Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates
Miércoles 13 de Noviembre 2024 (1 mes hace) • GlobeNewswire Inc.

Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference
Martes 12 de Noviembre 2024 (1 mes hace) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Jueves 31 de Octubre 2024 (2 meses hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jueves 24 de Octubre 2024 (2 meses hace) • Edgar (US Regulatory)

Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting
Jueves 24 de Octubre 2024 (2 meses hace) • GlobeNewswire Inc.

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings
Miércoles 16 de Octubre 2024 (2 meses hace) • GlobeNewswire Inc.

Pharvaris to Host Virtual Investor Event on October 23, 2024
Martes 15 de Octubre 2024 (2 meses hace) • GlobeNewswire Inc.

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop
Jueves 3 de Octubre 2024 (3 meses hace) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Miércoles 25 de Septiembre 2024 (3 meses hace) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lunes 23 de Septiembre 2024 (3 meses hace) • Edgar (US Regulatory)

Más de Pharvaris NV Artículos de Noticias

American Express

Bank of America

Health Care Select Sector

Energy Select Sector SPDR

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones